Even better outcomes are seen with surgical procedures like the gastric sleeve, which yield up to 5x the weight loss than even the most powerful GLP-1
First the good news: GLP-1s can help offset the very real and very common issue of postmenopausal weight gain, says Tan
Improvements in heart failure outcomes with GLP-1 receptor agonists have thus far been demonstrated only with specific agents such as subcutaneous semaglutide [25], the first in class dual glucose-dependent insulinotropic polypeptide/GLP-1 receptor agonist tirzepatide [26], as well as the nonsteroidal mineralocorticoid receptor antagonist finerenone [27]
BAT activation increases energy expenditure above basal metabolic rate without requiring exercise
Both effects are theoretically relevant to human metabolic health, and some early research on Melanotan 2s fat loss potential is genuinely promising
Histone deacetylases (HDACs), in particular, have emerged as key regulators of astrocyte-mediated neuroinflammation and neurodegeneration